Google
CMPS 株価分析 — COMPASS PATHWAYS PLC (Healthcare >> Medical Care Facilities)
CMPS に関するよくある質問
CMPSのPER（株価収益率）は？
COMPASS PATHWAYS PLC（CMPS）は現在PER 17.12倍で取引されています。
CMPSのROE（自己資本利益率）は？
COMPASS PATHWAYS PLCのROEは-54.73%です。
CMPSの配当利回りは？
COMPASS PATHWAYS PLCの配当利回りは0.00%です。
CMPSの品質スコア（Quality Score）は？
当社のAIはCMPSの総合財務品質を100点中38点と評価しています。収益性・成長性・負債・利益の安定性に基づく評価です。
CMPSは今が買い時ですか？
当社AIのタイミングスコアは100点中55点で、テクニカル指標とモメンタムから見た現在価格の相対的な魅力度を示します。
CMPSはどのセクターに属しますか？
COMPASS PATHWAYS PLCはHealthcare >> Medical Care Facilitiesセクターに分類されます（NASDAQ市場）
CMPS AI Analysis Summary
Our AI summary for CMPS: COMPASS PATHWAYS PLC (NASDAQ), Healthcare >> Medical Care Facilities sector. The stock currently trades at a P/E of 17.12, ROE of -54.73%, a dividend yield of 0.00%. Its financial Quality Score stands at 38/100 — fundamentals below the market average. The AI Timing Score is 55/100 — technical signals are mixed; watch for a clearer trend. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.
|
USD 11.35
Price
-0.22
(-1.90%)
Day Change
|
|
|---|
CMPS, ファンダメンタルスコアはnot good ( ファンダメンタル = 38) そして テクニカルスコアは ...(Sign In to See)...
Loading chart...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
ROEが低い
ROAが低い
ROEの伸びが低い
ROEが昨年度比で低い
ROAがROEに比べて低い
Last-year ROA is lower than last-2-years ROA.
NPMが低い
NPMの伸びが低い
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Momentum indicators aligned on the daily timeframe
In details, quality factors are not good , financial health is not good , and ability to make profit is not good , ...
| Deepscope 分析 |
|
45% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 98 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 11.35 |
| PBV / Sector |
4.78 / 318.17
|
| Earning Per Share | -1.30 |
| PE / Sector |
17.12 / 22.57
|
| PEG or PE/Growth / Sector |
1.26 / 1.00
|
| Average 1M Daily Value |
55.26 M
|
| Average 1W Daily Value |
27.61 M
GREAT
|
| Timing Factors |
|
28% |
| Financial Health |
|
41% |
| ポイントになる統計 |
|
37% |
| 配当 |
|
4% |
| 登録情報 |
| Analyze Date | 2026-08-01 07:59:39 |
| Symbol | CMPS |
| Name | COMPASS PATHWAYS PLC |
| Sector | Healthcare >> Medical Care Facilities |
| Market | NASDAQ |
| Listed Shares | 134.95 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 1,561.36 / 6,824.03 |
| ニュース |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 33 Broadwick Street, London, United Kingdom, W1F 0DQ
Phone: 44 716 6766461
Website: https://compasspathways.com
Employees: 156
Description: COMPASS Pathways plc operates as a biotechnology company that focuses on mental health in the United Kingdom and the United States. The company develops COMP360, a psilocybin therapy, which is in Phase III clinical trial for the treatment of treatment-resistant depression; and is in Phase II clinical trial for treating post-traumatic stress disorder and anorexia nervosa. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020. The company was incorporated in 2020 and is headquartered in London, the United Kingdom.
Analyst Ratings & Target Price
ME vs SECTOR Healthcare >> Medical Care Facilities
Click a bubble to view stock details · Bubble size represents market capitalization share
